Managing Enhanced Recovery Protocols

Documents to Request

• Applicable ERAS Society guideline document
• Institutional ERAS order set
• Patient education materials for the specific ERAS pathway
• Preoperative assessment results (labs, imaging, nutritional screen)
• Anesthesia plan aligned with ERAS elements
• Prior ERAS compliance data for the surgical team (if available)

Step 1: Preoperative ERAS Elements

Implement all preoperative elements with documentation:

Document compliance for each element: YES (completed) / NO (omitted with reason) / N/A (not applicable).

Step 2: Intraoperative ERAS Elements

Document each element's compliance intraoperatively. The anesthesia record and circulating nurse documentation should capture fluid volumes, temperature, antibiotic timing, and PONV prophylaxis.

Step 3: Postoperative ERAS Elements (POD 0-1)

Track and document hourly ambulation minutes and oral intake volumes.

Step 4: Discharge Criteria and Extended Recovery

Standardized Discharge Criteria (all must be met)

• Tolerating regular diet without nausea/vomiting
• Pain controlled on oral medications (NRS ≤4, meeting functional goals)
• Ambulating independently at baseline level
• Afebrile (T <38.0°C) for ≥24 hours
• No clinical signs of surgical complication
• Bowel function returned (passing flatus or BM — for GI surgery)
• Drain output acceptable for removal or patient educated on home drain care
• VTE prophylaxis plan for post-discharge documented (if extended course indicated)
• Follow-up appointment scheduled
• Patient demonstrates understanding of discharge instructions

Expected Length of Stay by ERAS Protocol

Step 5: Compliance Tracking and Quality Improvement

Element-Level Compliance Dashboard

Track compliance for each ERAS element per patient and aggregate by surgeon/service:

Compliance Rate = (Elements Completed / Total Applicable Elements) x 100

Target: ≥80% overall compliance; no single element below 60%

Monthly ERAS Report Structure

1. Volume: Number of patients on the ERAS pathway
2. Compliance: Overall rate and element-by-element breakdown
3. Outcomes:
   • Average length of stay vs. ERAS target
   • 30-day complication rate (Clavien-Dindo ≥ II)
   • 30-day readmission rate
   • ED visit rate within 30 days
   • Opioid consumption (average OME at discharge)
4. Variance analysis: Identify the lowest-compliance elements and root causes
5. Action items: Targeted interventions for low-compliance elements

Common compliance failures and interventions:

Checkpoint B: Post-Draft Alignment (Mandatory)

1. Has every applicable ERAS element been documented as completed, omitted (with reason), or N/A?
2. Is the overall compliance rate calculated and ≥80%?
3. Are the expected LOS targets set and communicated to the patient and care team?
4. Is the discharge criteria checklist being used to drive discharge decisions?
5. Are monthly ERAS compliance and outcomes reports being generated?

Quality Audit

• Patient education on ERAS pathway documented preoperatively
• Nutritional screening completed; supplements initiated if indicated
• Carbohydrate loading administered per protocol
• Fasting limited to 2h clear liquids / 6h solids
• Antibiotic prophylaxis given within 60 min of incision
• Goal-directed fluid therapy used intraoperatively
• Normothermia maintained (≥36.0°C)
• Minimally invasive approach used (or reason for open documented)
• PONV prophylaxis administered (multimodal)
• Early oral intake initiated POD 0
• Early mobilization documented (time out of bed POD 0)
• Multimodal analgesia with opioid-sparing approach documented
• Foley catheter removed POD 1 (or reason for delay documented)
• Discharge criteria checklist used
• ERAS compliance rate calculated per patient

Guidelines

1. ERAS is a pathway, not a menu — the benefit comes from high compliance across ALL elements, not cherry-picking individual components. Each element omitted reduces the cumulative benefit.
2. Carbohydrate loading and limited fasting are safe in non-diabetic patients without gastroparesis. For diabetics, modify the carbohydrate load volume and check glucose on arrival.
3. Goal-directed fluid therapy reduces complications compared to both liberal and overly restrictive fluid strategies — the target is euvolemia, not a specific volume.
4. Early oral intake on POD 0 is safe even after colorectal surgery — multiple RCTs and meta-analyses confirm this does not increase anastomotic leak rates.
5. The single strongest predictor of ERAS success at the institutional level is compliance tracking with feedback to the care team — without measurement, compliance degrades to <50% within 6 months.
6. Do not use ERAS target LOS as a discharge mandate — patients must meet all discharge criteria regardless of POD number.
7. Extended VTE prophylaxis (28 days of LMWH) is recommended for major abdominal/pelvic cancer surgery per ERAS and ASCO guidelines.
8. Engage the entire perioperative team (surgery, anesthesia, nursing, PT, pharmacy, nutrition) in ERAS education — compliance depends on every team member executing their elements.